Status:

UNKNOWN

Action Observation Therapy and Mirror Therapy in Parkinson's Disease

Lead Sponsor:

Kirsehir Ahi Evran Universitesi

Conditions:

Parkinson Disease

Tremor

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Small muscles of the hand are affected due to involuntary movements and slowing of voluntary movements seen in Parkinson's disease. There is a loss of fine dexterity and coordination in the hand. It b...

Eligibility Criteria

Inclusion

  • 18 years and older,
  • Diagnosed with idiopathic Parkinson's disease,
  • Parkinson's disease stage (patients with Hoehn Yahr≤3)
  • Patients who can hear and follow verbal instructions.

Exclusion

  • Patients who cannot cooperate,
  • Patients with dementia or comorbidities affecting cognitive functions,
  • Patients with serious comorbidities (such as decompensated heart failure, decompensated kidney failure) and significant disability (such as vision loss, hearing loss) affecting functionality,
  • Patients with another disease (such as inflammatory diseases, polyneuropathy, brachial plexus lesion, loss of range of motion after trauma) affecting upper extremity functions.
  • Patients diagnosed with secondary Parkinson's disease
  • Patients with acute neurological disease

Key Trial Info

Start Date :

April 25 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 15 2022

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT05350709

Start Date

April 25 2022

End Date

October 15 2022

Last Update

April 28 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.